• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

朊病毒病:实验模型与现实。

Prion disease: experimental models and reality.

机构信息

Department of Neurodegenerative Disease, UCL Institute of Neurology and Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, WC1N 3BG, UK.

出版信息

Acta Neuropathol. 2017 Feb;133(2):197-222. doi: 10.1007/s00401-017-1670-5. Epub 2017 Jan 13.

DOI:10.1007/s00401-017-1670-5
PMID:28084518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5250673/
Abstract

The understanding of the pathogenesis and mechanisms of diseases requires a multidisciplinary approach, involving clinical observation, correlation to pathological processes, and modelling of disease mechanisms. It is an inherent challenge, and arguably impossible to generate model systems that can faithfully recapitulate all aspects of human disease. It is, therefore, important to be aware of the potentials and also the limitations of specific model systems. Model systems are usually designed to recapitulate only specific aspects of the disease, such as a pathological phenotype, a pathomechanism, or to test a hypothesis. Here, we evaluate and discuss model systems that were generated to understand clinical, pathological, genetic, biochemical, and epidemiological aspects of prion diseases. Whilst clinical research and studies on human tissue are an essential component of prion research, much of the understanding of the mechanisms governing transmission, replication, and toxicity comes from in vitro and in vivo studies. As with other neurodegenerative diseases caused by protein misfolding, the pathogenesis of prion disease is complex, full of conundra and contradictions. We will give here a historical overview of the use of models of prion disease, how they have evolved alongside the scientific questions, and how advancements in technologies have pushed the boundaries of our understanding of prion biology.

摘要

对疾病发病机制和机理的认识需要采用多学科的方法,包括临床观察、与病理过程的相关性,以及疾病机理的建模。这是一个固有的挑战,可以说,生成能够忠实地再现人类疾病所有方面的模型系统是不可能的。因此,了解特定模型系统的潜力和局限性非常重要。模型系统通常旨在再现疾病的特定方面,例如病理表型、病理机制,或验证假说。在这里,我们评估和讨论了为了解朊病毒病的临床、病理、遗传、生化和流行病学方面而生成的模型系统。虽然临床研究和对人体组织的研究是朊病毒研究的一个重要组成部分,但对控制朊病毒传播、复制和毒性的机制的大部分了解来自体外和体内研究。与其他由蛋白质错误折叠引起的神经退行性疾病一样,朊病毒病的发病机制非常复杂,充满了难题和矛盾。在这里,我们将回顾性地介绍朊病毒病模型的使用情况,以及它们如何随着科学问题的发展而演变,以及技术的进步如何推动我们对朊病毒生物学理解的边界。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/5ce74caa51af/401_2017_1670_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/0142e10ea09b/401_2017_1670_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/acaa35b2104a/401_2017_1670_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/ff12fe367125/401_2017_1670_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/9b1001f4ec5f/401_2017_1670_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/5fd3c937fd7c/401_2017_1670_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/5ce74caa51af/401_2017_1670_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/0142e10ea09b/401_2017_1670_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/acaa35b2104a/401_2017_1670_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/ff12fe367125/401_2017_1670_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/9b1001f4ec5f/401_2017_1670_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/5fd3c937fd7c/401_2017_1670_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bf/5250673/5ce74caa51af/401_2017_1670_Fig6_HTML.jpg

相似文献

1
Prion disease: experimental models and reality.朊病毒病:实验模型与现实。
Acta Neuropathol. 2017 Feb;133(2):197-222. doi: 10.1007/s00401-017-1670-5. Epub 2017 Jan 13.
2
Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds.用于研究朊病毒病发病机制和鉴定潜在治疗化合物的实验模型。
Curr Opin Pharmacol. 2019 Feb;44:28-38. doi: 10.1016/j.coph.2019.02.002. Epub 2019 Mar 14.
3
Pathologic conformations of prion proteins.朊病毒蛋白的病理构象
Annu Rev Biochem. 1998;67:793-819. doi: 10.1146/annurev.biochem.67.1.793.
4
Approach To Identify Key Amino Acids in Low Susceptibility of Rabbit Prion Protein to Misfolding.鉴定兔朊病毒蛋白不易错误折叠的关键氨基酸的方法。
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01543-17. Print 2017 Dec 15.
5
The cellular and pathologic prion protein.细胞性和病理性朊病毒蛋白。
Handb Clin Neurol. 2018;153:21-44. doi: 10.1016/B978-0-444-63945-5.00002-7.
6
Transgenic mouse models of prion diseases.朊病毒疾病的转基因小鼠模型。
Methods Mol Biol. 2008;459:249-63. doi: 10.1007/978-1-59745-234-2_17.
7
Misfolding leads the way to unraveling signaling pathways in the pathophysiology of prion diseases.错误折叠为揭示朊病毒疾病病理生理学中的信号通路指明了方向。
Prion. 2016 Nov;10(6):434-443. doi: 10.1080/19336896.2016.1244593.
8
Prion diseases: from molecular biology to intervention strategies.朊病毒疾病:从分子生物学到干预策略
Chembiochem. 2003 Dec 5;4(12):1268-84. doi: 10.1002/cbic.200300704.
9
Prion-like transmission of pathogenic protein aggregates in genetic models of neurodegenerative disease.神经退行性疾病遗传模型中致病蛋白聚集体的类朊病毒传播
Curr Opin Genet Dev. 2017 Jun;44:149-155. doi: 10.1016/j.gde.2017.03.011. Epub 2017 Apr 22.
10
Proteomics applications in prion biology and structure.蛋白质组学在朊病毒生物学和结构中的应用。
Expert Rev Proteomics. 2015 Apr;12(2):171-84. doi: 10.1586/14789450.2015.1019481.

引用本文的文献

1
Characterization of prion strains and peripheral prion infectivity patterns in E200K genetic CJD patients.E200K基因型克雅氏病患者中朊病毒株及外周朊病毒感染模式的特征分析
Acta Neuropathol. 2025 Jun 16;149(1):62. doi: 10.1007/s00401-025-02903-5.
2
Cofactors facilitate bona fide prion misfolding in vitro but are not necessary for the infectivity of recombinant murine prions.辅因子在体外促进真正的朊病毒错误折叠,但对于重组鼠朊病毒的感染性并非必需。
PLoS Pathog. 2025 Jan 22;21(1):e1012890. doi: 10.1371/journal.ppat.1012890. eCollection 2025 Jan.
3
Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research.

本文引用的文献

1
Mammalian prions and their wider relevance in neurodegenerative diseases.哺乳动物朊病毒及其在神经退行性疾病中的广泛关联
Nature. 2016 Nov 10;539(7628):217-226. doi: 10.1038/nature20415.
2
The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases.实时震动诱导转换分析检测人类朊病毒病及其他蛋白质错误折叠疾病的研究。
Nat Protoc. 2016 Nov;11(11):2233-2242. doi: 10.1038/nprot.2016.120. Epub 2016 Oct 13.
3
Bioassay of prion-infected blood plasma in PrP transgenic Drosophila.
单域抗体和适体为神经退行性疾病研究带来新机遇。
Front Immunol. 2024 Aug 22;15:1426656. doi: 10.3389/fimmu.2024.1426656. eCollection 2024.
4
Convergent generation of atypical prions in knockin mouse models of genetic prion disease.在遗传性朊病毒病的敲入小鼠模型中异常朊病毒的趋同产生。
J Clin Invest. 2024 Aug 1;134(15):e176344. doi: 10.1172/JCI176344.
5
Comparing Prion Proteins Across Species: Is Zebrafish a Useful Model?跨物种比较朊病毒蛋白:斑马鱼是一个有用的模型吗?
Mol Neurobiol. 2025 Jan;62(1):832-845. doi: 10.1007/s12035-024-04324-z. Epub 2024 Jun 25.
6
NG2 glia protect against prion neurotoxicity by inhibiting microglia-to-neuron prostaglandin E2 signaling.NG2 胶质细胞通过抑制小胶质细胞向神经元的前列腺素 E2 信号传递来保护神经免受朊病毒毒性的侵害。
Nat Neurosci. 2024 Aug;27(8):1534-1544. doi: 10.1038/s41593-024-01663-x. Epub 2024 May 27.
7
Human prion diseases and the prion protein - what is the current state of knowledge?人类朊病毒疾病与朊病毒蛋白——当前的知识状况如何?
Transl Neurosci. 2023 Oct 16;14(1):20220315. doi: 10.1515/tnsci-2022-0315. eCollection 2023 Jan 1.
8
Potential Therapeutic Use of Stem Cells for Prion Diseases.干细胞在朊病毒病中的潜在治疗用途。
Cells. 2023 Oct 7;12(19):2413. doi: 10.3390/cells12192413.
9
Infections and immunity: associations with obesity and related metabolic disorders.感染与免疫:与肥胖及相关代谢紊乱的关联
J Pathol Transl Med. 2023 Jan;57(1):28-42. doi: 10.4132/jptm.2022.11.14. Epub 2023 Jan 15.
10
Analysis of non-human primate models for evaluating prion disease therapeutic efficacy.用于评估朊病毒病治疗效果的非人灵长类动物模型分析。
PLoS Pathog. 2022 Aug 22;18(8):e1010728. doi: 10.1371/journal.ppat.1010728. eCollection 2022 Aug.
在朊蛋白转基因果蝇中对感染朊病毒的血浆进行生物测定。
Biochem J. 2016 Dec 1;473(23):4399-4412. doi: 10.1042/BCJ20160417. Epub 2016 Oct 12.
4
The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6.朊病毒蛋白是G蛋白偶联受体Adgrg6的激动剂配体。
Nature. 2016 Aug 25;536(7617):464-8. doi: 10.1038/nature19312. Epub 2016 Aug 8.
5
Towards authentic transgenic mouse models of heritable PrP prion diseases.迈向遗传性朊蛋白病的真实转基因小鼠模型。
Acta Neuropathol. 2016 Oct;132(4):593-610. doi: 10.1007/s00401-016-1585-6. Epub 2016 Jun 28.
6
A neuroprotective role for microglia in prion diseases.小胶质细胞在朊病毒疾病中的神经保护作用。
J Exp Med. 2016 May 30;213(6):1047-59. doi: 10.1084/jem.20151000. Epub 2016 May 16.
7
Strictly co-isogenic C57BL/6J-Prnp-/- mice: A rigorous resource for prion science.严格同基因的C57BL/6J-Prnp-/-小鼠:朊病毒科学的严谨资源。
J Exp Med. 2016 Mar 7;213(3):313-27. doi: 10.1084/jem.20151610. Epub 2016 Feb 29.
8
Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.在感染人类 MM2-皮质型克雅氏病朊病毒的绵羊朊蛋白转基因小鼠中出现两种朊病毒亚型。
Acta Neuropathol Commun. 2016 Feb 5;4:10. doi: 10.1186/s40478-016-0284-9.
9
Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases.格斯特曼-施特劳斯勒-谢inker病亚型作为真正的朊病毒疾病在小林姬鼠中高效传播。
Sci Rep. 2016 Feb 4;6:20443. doi: 10.1038/srep20443.
10
Differential Toxicity of Antibodies to the Prion Protein.抗朊病毒蛋白抗体的差异毒性
PLoS Pathog. 2016 Jan 28;12(1):e1005401. doi: 10.1371/journal.ppat.1005401. eCollection 2016 Jan.